跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16 条关于
“C5aR1”
全部
16
临床试验
6
药物
5
机构
0
资讯
5
10个月前
Biogen Acquires Exclusive Rights to Vanqua Bio's C5aR1 Antagonist for Inflammatory Diseases in $1.06 Billion Deal
上个月
EMA Revokes Avacopan (Tavneos) After GCP Breaches in ADVOCATE Trial, as FDA Hearing Looms
10个月前
InflaRx's Oral C5aR Inhibitor INF904 Shows Biologic-Like Efficacy in Phase 2a Trials for Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
2个月前
UQ Researchers Develop First Drug Targeting Elusive C5aR2 Receptor, Paving Path to Transform MND into a Manageable Chronic Condition
10个月前
InflaRx to Report Phase 2a Results for Oral C5aR Inhibitor INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria